热门出版物 - 学术资源搜索

h5 指数:33
h5 中位数:52

h5 指数是指在过去整整 5 年中所发表文章的 h 指数。h 指在 2018-2022 年间发表的 h 篇文章每篇至少都被引用过 h 次的最大值。隐藏

出版物的 h5 中位数，是指出版物的 h5 指数所涵盖的所有文章获得的引用次数的中位值。隐藏

#18 Medicinal Chemistry

标题/作者	引用次数	年份
Characteristics of flavonoids as potent MERS‐CoV 3C‐like protease inhibitors S Jo, H Kim, S Kim, DH Shin, MS Kim Chemical Biology & Drug Design 94 (6), 2023-2030	198	2019
Homology modeling in drug discovery: Overview, current applications, and future perspectives MT Muhammed, E Aki‐Yalcin Chemical Biology & Drug Design 93 (1), 12-20	152	2019
tRF‐Leu‐CAG promotes cell proliferation and cell cycle in non‐small cell lung cancer Y Shao, Q Sun, X Liu, P Wang, R Wu, Z Ma Chemical Biology & Drug Design 90 (5), 730-738	106	2017
Design features for optimization of tetrapyrrole macrocycles as antimicrobial and anticancer photosensitizers A Martinez De Pinillos Bayona, P Mroz, C Thunshelle, MR Hamblin Chemical Biology & Drug Design 89 (2), 192-206	102	2017
Synthesis, molecular modeling, and biological evaluation of 4‐[5‐aryl‐3‐(thiophen‐2‐yl)‐4, 5‐dihydro‐1H‐pyrazol‐1‐yl] benzenesulfonamides toward acetylcholinesterase, carbonic anhydrase I and II enzymes C Yamali, HI Gul, A Ece, P Taslimi, I Gulcin Chemical Biology & Drug Design 91 (4), 854-866	94	2018
The recent challenges of highly contagious COVID‐19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy RK Mohapatra, L Pintilie, V Kandi, AK Sarangi, D Das, R Sahu, ... Chemical Biology & Drug Design 96 (5), 1187-1208	87	2020
Therapeutic potential of chemically modified si RNA: Recent trends C Selvam, D Mutisya, S Prakash, K Ranganna, R Thilagavathi Chemical Biology & Drug Design 90 (5), 665-678	79	2017
Computational methods and tools to predict cytochrome P450 metabolism for drug discovery JD Tyzack, J Kirchmair Chemical Biology & Drug Design 93 (4), 377-386	78	2019
Naphthoquinones: A continuing source for discovery of therapeutic antineoplastic agents HY Qiu, PF Wang, HY Lin, CY Tang, HL Zhu, YH Yang Chemical Biology & Drug Design 91 (3), 681-690	73	2018
Breast tumor stroma: A driving force in the development of resistance to therapies M Majidinia, B Yousefi Chemical Biology & Drug Design 89 (3), 309-318	72	2017
Versatility of peptide nucleic acids (PNA s): role in chemical biology, drug discovery, and origins of life C Sharma, SK Awasthi Chemical Biology & Drug Design 89 (1), 16-37	65	2017
Natural compounds with xanthine oxidase inhibitory activity: A review A Mehmood, M Ishaq, L Zhao, B Safdar, A Rehman, M Munir, A Raza, ... Chemical Biology & Drug Design 93 (4), 387-418	58	2019
New liposomal doxorubicin nanoformulation for osteosarcoma: Drug release kinetic study based on thermo and pH sensitivity F Haghiralsadat, G Amoabediny, MH Sheikhha, B Zandieh‐doulabi, ... Chemical Biology & Drug Design 90 (3), 368-379	54	2017
ff14IDPs force field improving the conformation sampling of intrinsically disordered proteins D Song, W Wang, W Ye, D Ji, R Luo, HF Chen Chemical Biology & Drug Design 89 (1), 5-15	53	2017
Current state of a dual behaviour of antimicrobial peptides—Therapeutic agents and promising delivery vectors U Piotrowska, M Sobczak, E Oledzka Chemical Biology & Drug Design 90 (6), 1079-1093	52	2017
N‐acylsulfonamides: Synthetic routes and biological potential in medicinal chemistry A Ammazzalorso, B De Filippis, L Giampietro, R Amoroso Chemical Biology & Drug Design 90 (6), 1094-1105	52	2017
An overview on Vadimezan (DMXAA): The vascular disrupting agent A Daei Farshchi Adli, R Jahanban‐Esfahlan, K Seidi, S Samandari‐Rad, ... Chemical Biology & Drug Design 91 (5), 996-1006	52	2018
Metformin enhances doxorubicin sensitivity via inhibition of doxorubicin efflux in P‐gp‐overexpressing MCF‐7 cells V Shafiei‐Irannejad, N Samadi, B Yousefi, R Salehi, K Velaei, N Zarghami Chemical Biology & Drug Design 91 (1), 269-276	48	2018
AVC pred: an integrated web server for prediction and design of antiviral compounds A Qureshi, G Kaur, M Kumar Chemical Biology & Drug Design 89 (1), 74-83	47	2017
Structural properties of bioactive peptides with α‐glucosidase inhibitory activity MA Ibrahim, MJ Bester, AWH Neitz, ARM Gaspar Chemical Biology & Drug Design 91 (2), 370-379	46	2018

1 - 20

计算机程序会自动估算并确定日期和引用次数。